Early Phase 1 Glomerulonephritis Clinical Trials

2 recruitingEarly Phase 1

What is a Early Phase 1 trial?

Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.

Showing 1–2 of 2 trials

Recruiting

Early Phase 1

A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases

IgA Nephropathy (IgAN)Membranous NephropathyANCA-associated Vasculitis (AAV)/ANCA-associated Glomerulonephritis (AAGN)+2 more

Grit Biotechnology30 enrolled1 locationNCT07389499

Recruiting

Early Phase 1

A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.

SLEANCA-associated VasculitisIIM+5 more

Nanjing Bioheng Biotech Co., Ltd.84 enrolled1 locationNCT07203404